Business

CinCor Pharma Stock Surges on Deal to Be Acquired by AstraZeneca

Published

3 weeks ago

January 9, 2023

AstraZeneca

agreed to buy U.S. biotech company

CinCor Pharma

in a deal potentially valued at $1.8 billion, the British pharmaceutical giant said Monday.

The offer price of $26 a share represents a 121% premium to CinCor’s (ticker: CINC) closing price on Friday, and will see

AstraZeneca

(AZN.U.K.) pay $1.3 billion up front.

Source link